Navigation Links
Statistics & Data Corporation Selects MedNet Solutions As Strategic Technology Partner
Date:10/25/2012

MINNETONKA, Minn., Oct. 16, 2012 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Statistics & Data Corporation (SDC), a specialized Contract Research Organization (CRO) focused exclusively on delivering biostatistics and data management services to the life sciences industry, are pleased to announce that SDC has chosen MedNet's iMedNet EDC platform as their eClinical solution of choice.  As the latest member of the iMedNet Partner Program, SDC will be able to couple their personalized service and innovative clinical biometrics expertise with iMedNet EDC's extensive and highly configurable eClinical toolset to quickly and effectively support their customers' clinical research initiatives.

"After working together on multiple projects over the past 2 years, SDC is excited to announce the formalization of our partnership with MedNet Solutions," stated Dr. Richard Abelson, President at SDC. "We believe that the iMedNet platform is a next generation eClinical technology, and our team is looking forward to offering the functionality and flexibility of the system as SDC's primary solution to our clients."

"We are extremely pleased to solidify our strategic relationship with SDC – a quality organization committed to exceptional customer service and support," noted John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "iMedNet was selected by SDC after their exhaustive review of the eClinical solutions marketplace...just one example of their keen attention to detail.  It is very gratifying that iMedNet was ultimately selected by them as the best EDC system available to meet their requirements."

For more information on iMedNet EDC or the iMedNet Partner Program, please contact MedNet Solutions. For additional details on SDC's biostatistics and data management services, please contact SDC.

About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market.  MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes.  Since 2000, MedNet has successfully supported pharmaceutical, medical device, biotechnology, and contract research organizations (CROs) on clinical research conducted around the world.  These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

About Statistics & Data Corporation
Statistics & Data Corporation (SDC) provides innovative biostatistics and clinical data management services to pharmaceutical, biotechnology, and medical device companies, as well as CRO partners.  SDC is committed to providing experienced teams who take ownership of our clients' needs and provide positive engagement on projects.  SDC delivered on-time on over 99% of key project milestones since 2010, and has a proven track record for rapidly delivering analyses during project closeout (consistently providing top-line analysis within 3 business days of database lock). For more information, please visit www.sdcclinical.com.

Contact Information:

Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Jim Townsend
Director, Business Development
Statistics & Data Corporation
21 East 6th Street, Suite 110
Tempe, AZ  85281
USA
(480) 632-5468


'/>"/>
SOURCE MedNet Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
2. Increased Focus on Security Bolsters Growth of Biometrics Market in Asia-Pacific, Finds Frost & Sullivan
3. DARPA director: Revolutionary weapons require strong S&T partnerships
4. MARC travel awards announced for 2012 American Society for Bone & Mineral Research annual meeting
5. British team set to embark on ambitious Antarctic mission to penetrate & sample ancient buried lake
6. Controlling gait of horses may be possible, says key study from Texas A&M
7. NSBRI renews space life sciences graduate programs at MIT, Texas A&M
8. Genetic Engineering & Biotechnology News unveils Biotech Boulevard
9. NSF releases report detailing nationwide and state-by-state R&D activities
10. Symposium: Protein-Folding Diseases: Models & Mechanisms
11. Mining cleanup benefits from Texas A&M expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Cambridge, MA (PRWEB) , ... January 20, 2017 ... ... and scientific consulting and resource to the healthcare industry ( http://www.gandlscientific.com ), has ... to its expanding team of clinical and scientific consultants and contractors. This is ...
(Date:1/21/2017)... , Jan. 20, 2017 Interpace ... a company that provides clinically useful molecular diagnostic ... has entered into a securities purchase agreement with ... 855,000 shares of common stock in a registered ... Company has agreed to sell to the same ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
Breaking Biology Technology: